BOC Sciences Releases High-Standard GalNAc-siRNA Conjugation Services to Support siRNA Drug Delivery to Liver
New York, USA – December 29, 2022 – BOC Sciences today announced the release of premium GalNAc-siRNA conjugation services to further support the delivery of siRNA drugs to the liver. N-Acetylgalactosamine (GalNAc) is an amino sugar derivative of galactose and can be used as a targeting ligand in antisense oligonucleotides (ASO) and siRNA therapeutics. Meanwhile, […]










